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Effect of ascorbic acid on the 
consequences of acute alcohol 
consumption in humans 
This study examines the influence of ascorbic acid pretreatment on ethanol clearance, toxicity, and 
behavioral impairment after an acute dose of ethanol in humans. Ascorbic acid or a placebo was given to 
20 healthy male subjects for 2 weeks before ethanol consumption. The dose of ethanol was 0.95 gm/kg 
body weight and was consumed during a 21/2-hour period. Thirty minutes after ethanol consumption, 
motor coordination and intellectual function were assessed by Goldberg's "Finger-Finger" and "Serial 
Sevens" tests. In addition, color discrimination was measured with the use of the Farnsworth-Munsell 
100 Hue Color Test. Hourly blood samples were taken for 10 hours after ethanol consumption to measure 
serum triglyceride levels, blood lactate/pyruvate ratios, and serum enzymes. Blood ethanol clearance was 
also determined. Ethanol consumption elevated serum triglyceride levels and blood lactate/pyruvate ratios 
and impaired performance of the behavioral tests but did not alter serum enzyme levels. Ascorbic acid 
pretreatment resulted in significant enhancement in blood ethanol clearance and an increase in serum 
triglyceride levels after ethanol consumption in half of the subjects. Ascorbic acid pretreatment also resulted 
in improved motor coordination and color discrimination after ethanol consumption in half of the subjects. 
Ascorbic acid pretreatment did not influence elevated blood lactate/pyruvate ratios or impaired intellectual 
function. (CLIN PHARMACOL THER 1987;41:502-9.) 
Robert L. Susick, Jr., Ph.D., and Vincent G. Zannoni, Ph.D. Ann Arbor, Mich. 
The influence of ascorbic acid on the metabolism, 
toxicity, and behavioral impairment of alcohol has be- 
come of interest in recent years. We have previously 
described an in vitro ascorbic aciddependent ethanol 
oxidizing system that involves the peroxidic oxidation 
of ethanol by catalase.I Yunice et al.' demonstrated 
enhanced blood ethanol clearance in ascorbic acid pre- 
treated carotidcannulated guinea pigs infused with eth- 
anol. Krasner et al.' found enhanced blood ethanol 
clearance in healthy male volunteers after 2 weeks of 
pretreatment with 1.0 gm ascorbic acid per day. 
Yunice and Lindeman' found that pretreatment with 
the vitamin protected against the lethality of an acute 
dose of ethanol in mice and chronic ethanol exposure 
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in the rat. Susick et al.' have demonstrated in the guinea 
pig that high dietary levels of ascorbic acid protect 
against hepatic steatosis, necrosis, and elevated levels 
of SOOT and SGPT caused by chronic ethanol con- 
sumption. Protection against hepatic steatosis by ascor- 
bic acid was also found by Yunice et al.2 in guinea pigs 
chronically infused with ethanol. In addition, ascorbic 
acid has been shown to reverse the impaired swimming 
behavior of mice treated with an intoxicating dose of 
ethanol 
This study examines the influence of ascorbic acid 
pretreatment on ethanol clearance, toxicity, and behav- 
ioral impairment after an acute dose of ethanol in hu- 
mans. Blood ethanol clearance, serum enzymes, serum 
triglyceride levels, blood lactate/pyruvate ratios, and 
tests of motor coordination, intellectual function, and 
color discrimination were determined. All of these pa- 
rameters have been shown to be affected by acute eth- 
anol consumption in animals and humans.'" 
METHODS 
Study design. Each subject was used as his own 
control, proceeding once through the protocol with pla- 
cebo pretreatment and once with ascorbic acid pretreat- 
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ment. To rule out any learning effect with the behavioral 
tests, half of the subjects received the placebo pretreat- 
ment first and half received vitamin C pretreatment first. 
A minimum of 4 weeks passed between test days to 
avoid any carryover effect. The study was conducted 
in a double-blind manner; neither the subject nor ex- 
perimenter on the Clinical Research Unit was aware of 
the identity of the pretreatment regimen. 
Twenty healthy, nonsmoking male adults aged 22 to 
30 years obtained from the University of Michigan stu- 
dent population participated in the study. The health 
status, history, and average amount of alcohol con- 
sumption for each subject was assessed with an inter- 
view and a questionnaire. The group of students used 
for the study was highly selected with regard to their 
prior history of alcohol consumption. Subjects selected 
had, on average, a weekly alcohol consumption that 
did not exceed 3 ounces of ethanol. A complete blood 
chemistry and urine analysis were also performed on 
each subject before alcohol administration. There was 
no history of health problems, liver disease, or alco- 
holism in any of the subjects. The study protocol was 
approved by the University of Michigan Human Subject 
Review Committee and informed consent was obtained 
from each subject on a form approved by the Com- 
mittee. All studies were performed under medical su- 
pervision at the Clinical Research Center of the Uni- 
versity of Michigan Hospital on the test day, as well 
as the day before and after the test day when the baseline 
values were obtained. 
The study consisted of a 2-week pretreatment period 
during which the subject consumed either 1.0 gm timed 
release ascorbic acid or placebo (lactose) five times per 
day. The maximum, safest pharmacologic dose of the 
vitamin was used to determine if there was a vita- 
min C effect. No evidence has been found indicating, 
that a dose of 5 gm ascorbic acid per day, in a timed- 
release form, during a short period of time (2 weeks) 
results in any adverse reactions. In addition, no subject 
in the study reported any adverse symptoms while re- 
ceiving either the placebo or ascorbic acid. There were 
also no symptoms of vitamin C deficiency in any of the 
subjects on cessation of ascorbic acid treatment. The 
subjects recorded each dose that was taken on a data 
card and this record was collected weekly. Subjects 
were also given a bottle containing a known number of 
pills that was collected at the end of each week. During 
the 2-week pretreatment period, each subject refrained 
from alcohol, drugs of any kind, and foods high in 
vitamin C such as citrus fruits and juices and certain 
vegetables. With regard to their diet, the subjects were 
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given an extensive list of foods to avoid prepared by 
the Clinical Research Center Dietetic Department. The 
subjects were also specifically told during the extensive 
interview not to consume alcohol or any drugs during 
the course of the study. The 2-week pretreatment period 
was followed by the test day at which time ethanol 
consumption occurred. The subjects did not take any 
ascorbic acid or lactose on the test day. The last dose 
of vitamin or placebo was taken the night before the 
test day. The last dose of vitamin or placebo was taken 
the night before the test day. The day before and after 
the alcohol test day, blood samples were taken and the 
behavioral tests were performed to establish baseline 
values. 
Test day. The test day began at 8 AM with the in- 
sertion of an indwelling catheter into a forearm vein, 
and a single blood sample was taken. A small breakfast 
was served at 8:15 AM and at 9 AM alcohol consumption 
began. Each subject consumed a total of 0.95 gm eth- 
anol/kg body weight. The dose was divided into five 
equal amounts diluted to a 30% solution in gingerale 
and consumed during a 2 1/2-hour period. Blood samples 
were drawn every hour from 10 Am to 7 PM for deter- 
mination of the biochemical parameters. Breath sam- 
ples for the determination of blood ethanol concen- 
tration were taken every 1/2 hour from 9:30 AM until 
ethanol was cleared from the blood. Breath samples 
were analyzed with the Alco-Sensor III manufactured 
by Intoximeters, Inc., St. Louis, Mo. Chemical analy- 
sis of the blood by a GC head-space gas method was 
used to ensure the accuracy of the breath analyzer. By 
11:30 AM the alcohol was consumed and by 12 noon 
the blood ethanol concentration had reached a maxi- 
mum level. Behavioral tests to measure motor coordi- 
nation, intellectual function, and color discrimination 
were performed between 12 noon and 12:30 PM. Lunch 
was served at 12:45 PM and dinner at 5:30 PM. The test 
day ended at 7 PM. 
Blood analyses. Serum was isolated by centrifuga- 
tion of whole blood 30 minutes after it was drawn. 
Serum ascorbic acid levels were measured by the HPLC 
method of Sauberlich et al.' 
Lactate levels were determined in whole blood by 
the enzymatic, fluorometric method of Passonneau.' 
Pyruvate levels were determined in whole blood by the 
enzymatic, fluorometric method of Passonneau and 
Lowry.' 
SGOT and SGPT levels were determined by the spec- 
trophotometric method of Kessler et al.15 Levels of se- 
rum -y-glutamyltranspeptidase (SGGT) were deter- 
mined by the spectrophotometric method of Szasz. 16 
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Fig. 1. Effect of ascorbic acid pretreatment on blood ethanol 
clearance after an acute dose of 0.95 gm ethanol/kg body 
weight in 20 subjects. 
Serum triglyceride levels were determined by the en- 
zymatic, spectrophotometric method of Bucolo and 
David." 
Behavioral tests. All behavioral tests were admin- 
istered and scored by the same individual who was 
unaware of the pretreatment regimen. Before the first 
baseline value was obtained, each subject performed 
the tests a number of times to become familiar with 
them and achieve a consistent score. During the actual 
conduct of the study, all tests were run in duplicate and 
the values expressed as the mean except for the color 
discrimination test, which was administered singly. 
Motor coordination was assessed with the use of the 
established "Finger-Finger" test developed by Gold- 
berg.' A paper-covered disk, 31/2 inches in diameter, 
was attached to one forefinger of the subject and a 
thimble with a pointed steel tip was attached to the 
other forefinger. The subject (with arms extended) was 
asked to bring the forefingers together repeatedly, pro- 
ducing a pattern of dots on the paper. The area enclosed 
by the dots was used as the index of motor coordination. 
The area enclosed by the dots was determined with the 
use of an Apple 1IE computer. 
Intellectual function was assessed with the use of the 
"Serial Sevens" test established by Goldberg .18 The sub- 
ject subtracted 7 successively from a number between 
99 and 104. Numeric measures of speed and accuracy 
were recorded. 
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Fig. 2. Effect of ascorbic acid pretreatment on serum tri- 
glyceride levels after an acute dose of 0.95 gm ethanol/kg 
body weight in 20 subjects. 
The Farnsworth-Munsell 100 Hue Color Test was 
used for the measurement of color discrimination.'' The 
test consists of 85 separate plastic caps of finely varied 
hues that the observer arranges in order according to 
hue. 
Data analysis. Values for serum triglycerides, serum 
enzymes, and blood lactate-pyruvate ratios were plotted 
against time. Consistent baseline values were obtained. 
For each biochemical parameter, the baseline values 
were uninfluenced by the pretreatment regimen; there 
was no statistically significant difference in baseline 
values after either pretreatment regimen. The peak val- 
ues obtained on the test day were used for statistical 
comparison. Statistical analysis demonstrated that base- 
line values for the behavioral tests were also uninflu- 
enced by the pretreatment regimen with the exception 
of the color discrimination test, which varied 10% to 
50% between pretreatment regimens. Values obtained 
on the test day (day of alcohol administration) for motor 
coordination and intellectual function were used and 
values obtained on the test day for color discrimination 
were used after the baseline values were subtracted. 
Blood ethanol concentration was plotted against time 
and clearance was calculated by linear regression anal- 
ysis of the descending slope. The linear portion of the 
slope after 2 PM was used. 
Statistical significance was determined with the two- 
sided, paired Student t test by comparing values ob- 
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Fig. 3. Effect of ascorbic acid pretreatment on blood lactate/ 
pyruvate ratio after an acute dose of 0.95 gm ethanol/kg body 
weight in 20 subjects. 
tamed after ascorbic acid pretreatment with values 
obtained after placebo pretreatment unless specified 
otherwise. Differences were considered significant at a 
P value <0.05. 
RESULTS 
Ethanol was absorbed rapidly into the blood, with 
blood ethanol concentrations rising steadily during the 
period of consumption. For all subjects, irrespective of 
pretreatment regimen, maximum blood ethanol levels 
were observed with the breath sample taken at 12 noon, 
30 minutes after cessation of drinking. There was no 
statistically significant difference in the maximum 
blood ethanol level whether the subject was pretreated 
with placebo or the vitamin. The mean maximum blood 
ethanol concentration was 0.074 -± 0.009 gm/d1 after 
placebo pretreatment and 0.078 -± 0.010 gm/di after 
vitamin pretreatment. It is important to note that it was 
when the blood ethanol concentration was at its highest 
and not statistically different after either pretreatment 
regimen that the behavioral tests were administered. 
However, ascorbic acid pretreatment did result in a 
significant increase in blood ethanol clearance (P = 
0.02; Fig. 1). The P value represents statistical analysis 
of all of the data points. Ten subjects demonstrated 
>10% difference in clearance after vitamin pretreat- 
ment as compared with placebo pretreatment. Nine of 
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Fig. 4. Effect of ascorbic acid pretreatment on motor coor- 
dination after an acute dose of 0.95 gm ethanol/kg body 
weight in 20 subjects. 
these 10 subjects had an 11% to 74% increase in clear- 
ance; one subject had a 15% decrease. Of the remaining 
10 subjects, four had an increase in clearance from 1% 
to 10%, five had a decrease from 1% to 10%, and one 
had no change at all. It is interesting to note that those 
individuals who had the largest increase in clearance 
with ascorbic acid pretreatment were those who had the 
slowest clearances with the placebo. In addition, the 
individual with the highest increase (74%) was Oriental. 
Individuals with this genetic background have an in- 
creased probability of possessing atypical forms of al- 
cohol and acetaldehyde dehydrogenases, which may be 
responsible for altered metabolism and reaction to 
ethanol.' 9 
Ethanol consumption resulted in a twofold to fourfold 
increase in serum triglyceride levels. However, when 
ascorbic acid pretreatment is compared with placebo 
pretreatment, significantly higher levels of serum tri- 
glycerides are found (P = 0.01; Fig. 2). This P value, 
and all subsequent P values, represent statistical anal- 
ysis of all of the data points. Eleven subjects demon- 
strated >20% difference in serum triglyceride levels 
after ascorbic acid pretreatment as compared with pla- 
cebo pretreatment. Ten of these 11 subjects had a 36% 
to 133% increase in triglyceride levels; one subject had 
a 30% decrease. Of the remaining nine subjects, four 
had a 10% to 20% increase in serum triglyceride levels, 
Placebo Ascorbate Placebo Ascorbate 
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Fig. 5. Effect of ascorbic acid pretreatment on color discrim- 
ination after an acute dose of 0.95 gm ethanol/kg body weight 
in 13 subjects. 
four had a 1% to 20% decrease, and one had no change 
at all. 
Ethanol consumption also resulted in a twofold to 
fourfold increase in blood lactate/pyruvate ratios. How- 
ever, no significant difference was found in the ratios 
when ascorbic acid pretreatment was compared with 
placebo pretreatment (Fig. 3). Ethanol consumption did 
not elevate levels of SGOT, SGPT, or SGGT. 
Ethanol consumption resulted in impairment of motor 
coordination. Pretreatment with the vitamin resulted in 
significantly less impairment (P =- 0.03; Fig. 4). Thir- 
teen subjects demonstrated >20% difference in motor 
coordination after ascorbic acid pretreatment as com- 
pared with placebo pretreatment. Eleven of these 13 
subjects had a 21% to 50% improvement in motor co- 
ordination after vitamin pretreatment as compared with 
placebo pretreatment and two subjects had a decrease 
of 48% and 56%. Of the remaining seven subjects, one 
had an improvement in coordination of 14% and six 
had a decrease from 1% to 20%. 
Pretreatment with the vitamin also protected against 
ethanol's impairment of color discrimination (P = 
0.001; Fig. 5). Ten subjects demonstrated >20% dif- 
ference in color discrimination after ascorbic acid pre- 
treatment as compared with placebo pretreatment. Nine 
of these 10 subjects had a 20% to 100% improvement 
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Fig. 6. Effect of ascorbic acid pretreatment on intellectual 
function after an acute dose of 0.95 gm ethanol/kg body 
weight in 13 subjects. 
in color discrimination. The remaining three subjects 
had a 10% to 20% decrease in color discrimination. 
There are 13 subjects depicted in Fig. 5 because only 
13 subjects had impairment in color discrimination after 
ethanol consumption; the other seven subjects had 
scores after ethanol consumption that were the same as 
their baseline values. 
Thirteen of the 20 subjects had impaired intellectual 
function after ethanol consumption as compared with 
baseline values. However, no statistically significant 
effect of ascorbic acid pretreatment was observed in 
these subjects (Fig. 6). 
To assess the effect the order of pretreatment had on 
the results, a statistical comparison with a two-sided 
Student t test was performed. No statistically significant 
difference was found between the results of the behav- 
ioral tests or the biochemical values and the order in 
which the pretreatment regimen was administered. In 
addition, a possible pattern of the individual subject's 
response across all variables was examined. For ex- 
ample, to determine whether a positive response after 
vitamin pretreatment in ethanol clearance is associated 
with an increase in motor performance, elevated tri- 
glyceride levels, or enhanced color discrimination, 
Pearson product-moment correlations were calculated 
for all possible associations. No statistically significant 
50 - p = 0.001 
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correlation of individual response or lack of response 
to ascorbic acid pretreatment was found across two or 
more of the parameters. 
Serum ascorbic acid levels were determined at three 
different time points during the course of the test day. 
There was no statistically significant difference in the 
levels of ascorbic acid in the serum during the course 
of the day nor was there any statistically significant 
difference in serum ascorbic acid levels for any given 
subject after the two pretreatment regimens. Mean val- 
ues of serum ascorbic acid levels after placebo pretreat- 
ment were 28 ± 10 p,g/m1 and after ascorbic acid pre- 
treatment 28 ± 11 Rg/ml. This may be because ascor- 
bic acid is readily secreted from the blood at high doses 
and serum levels of the vitamin do not accurately reflect 
tissue levels.' In addition, serum ascorbic acid levels 
were measured at least 12 hours after cessation of vi- 
tamin consumption in a timed-release capsule form. 
DISCUSSION 
The metabolism of ethanol is mediated by three en- 
zyme systems. They include alcohol dehydrogenase 
(ADH), which requires NAD+ , catalase, which uses 
hydrogen peroxide, and the microsomal ethanoloxi- 
dizing system (MEOS), which requires NADPH and 
oxygen. ADH is considered to be the major pathway 
in ethanol oxidation in vivo.' MEOS is thought to play 
a minor role and catalase's contribution is thought to 
be insignificant since the in vivo rate of hydrogen per- 
oxide generation is limiting.' With regard to the latter, 
we have previously described and characterized an 
ascorbic aciddependent alcohol oxidizing system that 
is catalyzed by catalase. In this system, ascorbic acid 
generates a peroxide that is used by catalase in a per- 
oxidic oxidation of the alcohol. In the present study the 
ability of ascorbic acid pretreatment to enhance blood 
ethanol clearance (Fig. 1) may be the result of its ability 
to supply peroxide and thus allow catalase to contribute 
to ethanol oxidation. 
It is well established that ethanol affects lipoprotein 
metabolism and that an acute dose increases levels of 
serum and hepatic triglycerides.' Ethanol causes a 
number of events that lead to increased hepatic fat levels 
(e.g., a stress-induced mobilization of fat from adipose 
tissues, a decrease in the rate of fatty acid oxidation, 
an increase in the rate of fatty acid synthesis, and an 
increase in the esterification of fatty acids to triglyc- 
erides). In addition, ethanol inhibits export of fat from 
the liver by impairing the synthesis and secretion of 
very low-density lipoproteins (VLDL), the export form 
of triglycerides. The present study demonstrates that 
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with an acute dose of ethanol, ascorbic acid pretreat- 
ment causes an increase in serum triglyceride levels 
(Fig. 2). The possibility that the vitamin increases the 
rate of fat transport out of the liver should be consid- 
ered. This could be accomplished by a stimulation in 
the synthesis or secretion of the VLDL or by preventing 
alcohol's impairment of these processes. This mecha- 
nism would result in less fat accumulation in the liver. 
In keeping with this, previous in vivo studies in the 
guinea pig demonstrate that ascorbic acid pretreatment 
results in less hepatic steatosis after chronic ethanol 
consumption.2.5 Another mechanism to consider in- 
volves the stress-induced mobilization of fatty acids 
from the adipose tissue. The mobilization is mediated 
via the adrenal gland with release of catecholamines, 
which causes an increase in adipose tissue triglyceride 
lipolysis. The adrenal gland contains the highest con- 
centration of the vitamin and it is known that the vitamin 
is involved in catecholamine metabolism."'" It is not 
unreasonable that the adrenal-mediated mobilization of 
fat may be enhanced by high tissue concentrations of 
the vitamin. Although elevated serum triglyceride levels 
could be viewed as a protective effect of ascorbic acid 
pretreatment if it results in less fat in the liver, it could 
also be viewed as a detrimental effect if the elevated 
triglyceride levels proved harmful to other organs. 
It is known that increased blood lactate/pyruvate ra- 
tios after ethanol consumption reflect the increase in 
the hepatic NADH/NAD ± ratio resulting from ethanol 
oxidation via ADH. Blood lactatelpyruvate levels were 
monitored to determine if ascorbic acid pretreatment 
could reduce the hepatic NADH/NAD± ratio by pro- 
viding a non-ADH pathway for ethanol oxidation. Al- 
though ascorbic acid pretreatment did significantly in- 
crease blood ethanol clearance, there was no significant 
decrease in the elevated lactate/pyruv ate ratio ( Fig. 3). 
It is possible that the degree of enhanced ethanol clear- 
ance was not large enough to observe a significant re- 
duction in the lactate/pyruvate ratio. 
The participation of ascorbic acid in neurochemi- 
cal events is of current interest. Its involvement in 
Na+ /IC+ transport and metabolism of neurotransmitters 
including the synthesis of catecholamines, storage of 
norepinephrine, and regulation of dopaminergic trans- 
mission have been reported.'" In addition, the vitamin 
has been implicated in modulating the behavioral effects 
of antipsychotic drugs by influencing their binding to 
the dopamine receptor.' With regard to ethanol's im- 
pairment on behavior, ascorbic acid has been shown to 
prevent impaired swimming in mice caused by an in- 
toxicating dose of ethanol.' The protective effect of 
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ascorbic acid pretreatment on impaired motor coordi- 
nation caused by acute ethanol consumption demon- 
strated in this study (Fig. 4) supports a neurochemical 
role for the vitaminn. The protective effect is not caused 
by altered blood ethanol concentrations because ascor- 
bic acid pretreatment had no effect on ethanol concen- 
trations at the time the behavioral tests were adminis- 
tered. The mechanism of the protective action, be it 
through stabilization of the neuronal membrane, an ef- 
fect on Na+ /K + transport, an effect on the synthesis, 
storage, release, or binding of the neurotransmitters, 
or an as yet unknown mechanism, remains to be de- 
termined. 
Previous studies have also demonstrated ascorbic 
acid involvement in eye physiology and protection 
against cataract formation and inhibition of amino acid 
transport across the cornea membrane, which is caused 
by oxidative damage."' The vitamin's antioxidant and 
radical scavenging properties, as well as its potential 
to serve as an energy source for transport processes in 
the eye, have been implicated in its ability to afford 
this protection. In addition, ascorbic acid is actively 
secreted into ocular tissues and, in certain species, con- 
centrations may be twentyfold greater than in plasma." 
Impairment in color discrimination by ethanol has been 
postulated to be caused by a direct toxic effect of ethanol 
on the inner retina of the eye." The protection by ascor- 
bic acid against impaired color discrimination could be 
the result of its antioxidant properties or involvement 
in membrane transport. However, it is also possible that 
the impairment in color discrimination is caused by a 
general central nervous system effect resulting in lack 
of concentration and enhanced random errors. In this 
case the protection found with ascorbic acid pretreat- 
ment further supports a neurochemical role for the 
vitamin. 
The present clinical study demonstrates that ascorbic 
acid pretreatment is capable of influencing both bio- 
chemical and behavioral changes caused by an acute 
dose of ethanol. The influence of ascorbic acid pre- 
treatment, although not observed in every subject, was 
greatest in those subjects with the largest alcohol im- 
pairment of behavior and the slowest rates of ethanol 
elimination after placebo pretreatment. The results of 
this clinical study coupled with previous animal studies 
suggest that ascorbic acid may be of value in protecting 
against some harmful consequences of alcohol con- 
sumption in certain individuals. In addition, the deter- 
mination of the exact mechanisms by which ascorbic 
acid is acting may lead to the elucidation of important 
new biologic roles for the vitamin. 
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